These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1980623)

  • 1. [Study of dipeptidyl peptidase IV as a surface marker of human natural killer cells].
    Biuling F; Tonevitskiĭ AG; Kiuster U; Anzorge S
    Biull Eksp Biol Med; 1990 Oct; 110(10):411-3. PubMed ID: 1980623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and functional role of dipeptidyl peptidase IV (CD26) on human natural killer cells.
    Bühling F; Kunz D; Reinhold D; Ulmer AJ; Ernst M; Flad HD; Ansorge S
    Nat Immun; 1994; 13(5):270-9. PubMed ID: 7833626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human lymphokine-activated killer (LAK) cells: identification of two types of effector cells.
    Tilden AB; Itoh K; Balch CM
    J Immunol; 1987 Feb; 138(4):1068-73. PubMed ID: 3100627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lectin-binding characteristics of human natural killer cells.
    Vose BM; Blackledge G; Crowther D; Gallaher J
    Immunology; 1982 Jul; 46(3):619-27. PubMed ID: 7095832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of two subsets of human T gamma cells.
    van de Griend RJ; ten Berge I; Tanke HJ; Roos D; Schellekens PT; Melief CJ; Zeijlemaker WP; Astaldi A
    J Immunol; 1982 May; 128(5):1979-85. PubMed ID: 6977578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells.
    Suzuki R; Handa K; Itoh K; Kumagai K
    J Immunol; 1983 Feb; 130(2):981-7. PubMed ID: 6600260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD56 identifies monocytes and not natural killer cells in rhesus macaques.
    Carter DL; Shieh TM; Blosser RL; Chadwick KR; Margolick JB; Hildreth JE; Clements JE; Zink MC
    Cytometry; 1999 Sep; 37(1):41-50. PubMed ID: 10451505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 2 (IL 2) up-regulates its own receptor on a subset of human unprimed peripheral blood lymphocytes and triggers their proliferation.
    Harel-Bellan A; Bertoglio J; Quillet A; Marchiol C; Wakasugi H; Mishall Z; Fradelizi D
    J Immunol; 1986 Apr; 136(7):2463-9. PubMed ID: 3005412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of serum soluble CD26/dipeptidyl peptidase IV enzyme activity and its correlation with disease activity in systemic lupus erythematosus.
    Kobayashi H; Hosono O; Mimori T; Kawasaki H; Dang NH; Tanaka H; Morimoto C
    J Rheumatol; 2002 Sep; 29(9):1858-66. PubMed ID: 12233879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface antigen determinants in subpopulations of peripheral blood NK- and T-cells separated by Percoll density fractionation.
    Schlesinger M; Lew F; Bekesi JG
    J Clin Lab Immunol; 1984 Apr; 13(4):195-202. PubMed ID: 6204054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dipeptidyl peptidase IV--subcellular localization, activity and kinetics in lymphocytes from control subjects, immunodeficient patients and cord blood.
    Harland C; Shah T; Webster AD; Peters TJ
    Clin Exp Immunol; 1988 Nov; 74(2):201-5. PubMed ID: 2906280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Dipeptidyl aminopeptidase-IV in lymphocytes of patients with lymphoproliferative diseases].
    Bylinkina VS; Golubeva NV; Gureeva TA; Lokshina LA; Polianskaia AM; Samoĭlova RS
    Biull Eksp Biol Med; 1989 Jul; 108(7):85-8. PubMed ID: 2572281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preferential proliferation of natural killer cells among peripheral blood mononuclear cells cocultured with B lymphoblastoid cell lines.
    Perussia B; Ramoni C; Anegon I; Cuturi MC; Faust J; Trinchieri G
    Nat Immun Cell Growth Regul; 1987; 6(4):171-88. PubMed ID: 2960890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C-reactive protein antigenicity on the surface of human peripheral blood lymphocytes. Characterization of lymphocytes reactive with anti-neo-CRP.
    Bray RA; Samberg NL; Gewurz H; Potempa LA; Landay AL
    J Immunol; 1988 Jun; 140(12):4271-8. PubMed ID: 2453575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of interferon-gamma production by human natural killer cells stimulated by hydrogen peroxide.
    Munakata T; Semba U; Shibuya Y; Kuwano K; Akagi M; Arai S
    J Immunol; 1985 Apr; 134(4):2449-55. PubMed ID: 3919096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphokine-activated killer activity induced by in vivo interleukin 2 therapy: predominant role for lymphocytes with increased expression of CD2 and leu19 antigens but negative expression of CD16 antigens.
    Weil-Hillman G; Fisch P; Prieve AF; Sosman JA; Hank JA; Sondel PM
    Cancer Res; 1989 Jul; 49(13):3680-8. PubMed ID: 2471587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel population of natural killer progenitor cells isolated from human umbilical cord blood.
    Cicuttini FM; Martin M; Petrie HT; Boyd AW
    J Immunol; 1993 Jul; 151(1):29-37. PubMed ID: 7686936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the murine lymphokine-activated killer (LAK) cell phenomenon: dissection of effectors and progenitors into NK- and T-like cells.
    Kalland T; Belfrage H; Bhiladvala P; Hedlund G
    J Immunol; 1987 Jun; 138(11):3640-5. PubMed ID: 3495566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacterial activation of human natural killer cells. Characteristics of the activation process and identification of the effector cell.
    Tarkkanen J; Saksela E; Lanier LL
    J Immunol; 1986 Oct; 137(8):2428-33. PubMed ID: 3093576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapidly expanded activated human killer cell clones have strong antitumor cell activity and have the surface phenotype of either T gamma, T-non-gamma, or null cells.
    van de Griend RJ; van Krimpen BA; Ronteltap CP; Bolhuis RL
    J Immunol; 1984 Jun; 132(6):3185-91. PubMed ID: 6233369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.